.beta.-amyloid peptide-binding proteins and polynucleotides encoding the same
CA 2446640 A1 · Owner: Walker, Stephen Glenn · Inventors: Ozenberger, Bradley Alton; Howland, David Scott; Walker, Stephen Glenn
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel proteins which bind human .szlig.-amyloid peptide polynucleotides which , encode these proteins and methods for producing these proteins are provided. Diagnostic, therapeutic, and screening methods employing the polynucleotides and polypeptides of the present invention are also provided. Transgenic animals and knockout animals are also provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 6, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 6, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 6, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.